Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735858) titled 'Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer' on July 25.
Study Type: Observational
Primary Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Condition:
Bladder Cancer
Intervention:
Diagnostic Test: Liquid biopsy
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2025
Target Sample Size: 300
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07735858
Disclaimer: Curated by HT Syndication....